Molecular characterization of novel and rare DNA variants in patients with galactosemia
Introduction: Galactosemia is an inherited disorder caused by mutations in the three genes that encode enzymes implicated in galactose catabolism. Currently, the only available treatment for galactosemia is life-long dietary restriction of galactose/lactose, and despite treatment, it might result in...
Main Authors: | Vasileios Maroulis, Andreas Agathangelidis, Anastasia Skouma, Triantafyllia Sdogou, Manoussos N. Papadakis, Evangelos Papakonstantinou, Panagiotis Girginoudis, Constantinos E. Vorgias, Vassiliki Aleporou, Panagoula Kollia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1266353/full |
Similar Items
-
An unusual presentation of galactosemia: Hemophagocytic lymphohistiocytosis
by: Ahmet Afşin Kundak, et al.
Published: (2012-12-01) -
The Discovery of GALM Deficiency (Type IV Galactosemia) and Newborn Screening System for Galactosemia in Japan
by: Atsuo Kikuchi, et al.
Published: (2021-10-01) -
Twelve-year review of galactosemia newborn screening in Taiwan: Evolving methods and insights
by: Hui-An Chen, et al.
Published: (2024-03-01) -
Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment
by: Mariangela Succoio, et al.
Published: (2022-07-01) -
Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta
by: Nihal Almenabawy, et al.
Published: (2024-03-01)